Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings Gross Profit Margin (Quarterly) : 40.14% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.14% |
| March 31, 2026 | 51.19% |
| December 31, 2025 | 24.55% |
| September 30, 2025 | 12.14% |
| June 30, 2025 | 16.39% |
| March 31, 2025 | 16.49% |
| December 31, 2024 | 32.55% |
| September 30, 2024 | 45.68% |
| June 30, 2024 | 43.42% |
| March 31, 2024 | 29.57% |
| December 31, 2023 | 51.84% |
| September 30, 2023 | 44.09% |
| June 30, 2023 | 36.19% |
| March 31, 2023 | 56.50% |
| Date | Value |
|---|---|
| December 31, 2022 | 73.99% |
| September 30, 2022 | 79.67% |
| June 30, 2022 | 84.26% |
| March 31, 2022 | 83.29% |
| December 31, 2021 | 82.60% |
| September 30, 2021 | 83.54% |
| June 30, 2021 | 81.77% |
| March 31, 2021 | 77.54% |
| December 31, 2020 | 76.21% |
| September 30, 2020 | 75.35% |
| June 30, 2020 | 50.76% |
| March 31, 2020 | 66.27% |
| December 31, 2019 | 44.86% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp. | 49.25% |
| Bio-Techne Corp. | 65.22% |
| BioLife Solutions, Inc. | 63.69% |
| MindWalk Holdings Corp. | 58.58% |
| MaxCyte, Inc. | 63.86% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.07% |
| Return on Assets | -17.75% |
| Return on Invested Capital | -19.17% |
| Profit Margin (Quarterly) | -42.05% |
| Operating Margin (Quarterly) | -28.97% |
| Return on Net Operating Assets | -25.99% |